annual accounts payable:
$13.37M-$1.79M(-11.84%)Summary
- As of today (May 21, 2025), RPRX annual accounts payable is $13.37 million, with the most recent change of -$1.79 million (-11.84%) on December 31, 2024.
- During the last 3 years, RPRX annual accounts payable has risen by +$7.75 million (+137.90%).
- RPRX annual accounts payable is now -11.84% below its all-time high of $15.16 million, reached on December 31, 2023.
Performance
RPRX Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$37.63M+$24.26M(+181.45%)Summary
- As of today (May 21, 2025), RPRX quarterly accounts payable is $37.63 million, with the most recent change of +$24.26 million (+181.45%) on March 31, 2025.
- Over the past year, RPRX quarterly accounts payable has increased by +$26.08 million (+225.77%).
- RPRX quarterly accounts payable is now at all-time high.
Performance
RPRX quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
RPRX Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.8% | +225.8% |
| 3 y3 years | +137.9% | +464.9% |
| 5 y5 years | +19.6% | +81.3% |
RPRX Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.8% | +137.9% | at high | +547.8% |
| 5 y | 5-year | -11.8% | +137.9% | at high | +569.6% |
| alltime | all time | -11.8% | +198.6% | at high | +569.6% |
RPRX Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $37.63M(+181.5%) |
| Dec 2024 | $13.37M(-11.8%) | $13.37M(-39.4%) |
| Sep 2024 | - | $22.05M(-5.8%) |
| Jun 2024 | - | $23.42M(+102.7%) |
| Mar 2024 | - | $11.55M(-23.8%) |
| Dec 2023 | $15.16M(+91.8%) | $15.16M(+11.3%) |
| Sep 2023 | - | $13.63M(+134.6%) |
| Jun 2023 | - | $5.81M(-12.7%) |
| Mar 2023 | - | $6.66M(-15.8%) |
| Dec 2022 | $7.91M | $7.91M(-50.9%) |
| Sep 2022 | - | $16.11M(+32.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $12.18M(+82.8%) |
| Mar 2022 | - | $6.66M(+18.5%) |
| Dec 2021 | $5.62M(-47.8%) | $5.62M(-38.8%) |
| Sep 2021 | - | $9.19M(-2.2%) |
| Jun 2021 | - | $9.39M(+13.6%) |
| Mar 2021 | - | $8.27M(-23.2%) |
| Dec 2020 | $10.78M(-3.6%) | $10.78M(-55.8%) |
| Sep 2020 | - | $24.39M(-29.0%) |
| Jun 2020 | - | $34.37M(+65.6%) |
| Mar 2020 | - | $20.75M(+85.7%) |
| Dec 2019 | $11.18M(+149.7%) | $11.18M |
| Dec 2018 | $4.48M | - |
FAQ
- What is Royalty Pharma annual accounts payable?
- What is the all time high annual accounts payable for Royalty Pharma?
- What is Royalty Pharma annual accounts payable year-on-year change?
- What is Royalty Pharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for Royalty Pharma?
- What is Royalty Pharma quarterly accounts payable year-on-year change?
What is Royalty Pharma annual accounts payable?
The current annual accounts payable of RPRX is $13.37M
What is the all time high annual accounts payable for Royalty Pharma?
Royalty Pharma all-time high annual accounts payable is $15.16M
What is Royalty Pharma annual accounts payable year-on-year change?
Over the past year, RPRX annual accounts payable has changed by -$1.79M (-11.84%)
What is Royalty Pharma quarterly accounts payable?
The current quarterly accounts payable of RPRX is $37.63M
What is the all time high quarterly accounts payable for Royalty Pharma?
Royalty Pharma all-time high quarterly accounts payable is $37.63M
What is Royalty Pharma quarterly accounts payable year-on-year change?
Over the past year, RPRX quarterly accounts payable has changed by +$26.08M (+225.77%)